Delivery Order SPE2DB22D1106-SPE2DB25FEFB6
Award Date
3/27/25
Potential Completion Date
3/28/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.73 firm-fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract, which has an ultimate completion date of October 30, 2024, is a part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,595.17, is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 5, 2024. The contract is not designated...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,270.30 firm fixed-price delivery order (SPE2DB20D1100|SPE2DB25FY72H) is for the supply of Quillivant XR 25 mg/5 ml oral suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 28, 2024 and is part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,293.58 firm fixed-price contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. It is not designated as a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,616.00 firm fixed-price contract is for the supply of Quillivant XR Oral Suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is not associated with a set-aside program and has an ultimate completion date of April 14, 2025. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,668.75 Firm Fixed Price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,648.54 firm fixed price contract is for the supply of Quillivant XR 25 mg/5 mL oral suspension, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,057.00, is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of attention deficit hyperactivity disorder (ADHD). The contract has a firm fixed price pricing type and a performance period extending through May 9, 2025. This award is not associated...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,041.06 and a period of performance through March 26, 2025. It is a firm fixed-price delivery order contract...
This federal contract award, valued at $3,587.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of...